SCHEMBL17232864

SCHEMBL17232864

CCc1ccc(/C=C(\C#N)c2cccnc2)cc1OC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.77
▸ EGFR P00533 2/20 0.77
▸ RECQL P46063 1/20 0.77
▸ HIF1A Q16665 1/20 0.77
▸ PDGFRB P09619 1/20 0.77
▸ PDGFRA P16234 1/20 0.77
▸ MAPT P10636 3/20 0.54
▸ POLB P06746 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ CLK1 P49759 3/20 0.47
▸ DYRK1A Q13627 3/20 0.47
▸ KIF20A O95235 3/20 0.47
▸ CYP1A1 P04798 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP1B1 Q16678 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1959494 0.87 SMN1; SMN2 (1.00) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL31060645 0.87 SMN1; SMN2 (1.00) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL241869 0.87 SMN1; SMN2 (1.00) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL29800237 0.87 SMN1; SMN2 (1.00) SMN1; SMN2EGFRRECQLHIF1APDGFRB
Hydrochloric Acid SCHEMBL1957337 0.86 SMN1; SMN2 (0.98) SMN1; SMN2EGFRRECQLHIF1APDGFRB
Hydrochloric Acid SCHEMBL1957339 0.86 SMN1; SMN2 (0.98) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL17232854 0.85 EGFR (0.82) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL8335044 0.85 SMN1; SMN2 (0.61) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL6782225 0.83 EGFR (0.82) SMN1; SMN2EGFRRECQLHIF1APDGFRB
SCHEMBL6782228 0.83 EGFR (0.82) SMN1; SMN2EGFRRECQLHIF1APDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015166042-A1 STILBENE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER DE MONTFORT UNIVERSITY (GB) 2015-11-05 — — WO disclosed
Send feedback